Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Wayne Balkan
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone-Releasing Hormone (GHRH)
Abstract Heart failure (HF) with preserved ejection fraction (HFpEF) carries a high mortality and remains a major therapeutic challenge. Effective, targeted therapies capable of reversing HFpEF pathophysiology are urgently needed.
Mesenchymal STRO-1/STRO-3+ precursor cells for the treatment of chronic heart failure with reduced ejection fraction
This work was supported by the National Institutes of Health grant 1R01HL134558-01, Department of Defense grant W81XWH-19-PRMRP-CTA and Soffer Family, Lipson Family, Marcus Family and Starr Foundations to JM Hare. JM Hare, is the Chief Scientific Officer, a compensated consultant and board member for Longeveron, and holds equity in Longeveron. He is also the co-inventor of intellectual property licensed to Longeveron.
Preclinical Studies of Stem Cell Therapy for Heart Disease
As part of the TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) series to enhance regenerative medicine, here, we discuss the role of preclinical studies designed to advance stem cell therapies for cardiovascular disease. The quality of this research has improved over the past 10 to 15 years and overall indicates that cell therapy promotes cardiac repair. However, many issues remain, including inability to provide complete cardiac recovery.
What Is the Future of Cell-Based Therapy for Acute Myocardial Infarction
Although therapy for cardiovascular disease has led to consistent annual declines in mortality, myocardial infarction still represents an irreversible injury to the myocardium leading to the substrate for heart failure and sudden cardiac death.1 Indeed, the extent of scar resulting from myocardial infarction is an important predictor of mortality.2 Even with timely coronary intervention, infarct size is a significant problem likely exacerbated by ischemia/reperfusion injury.3 Supported by...
Sympathetic Reinnervation Is Required for Mammalian Cardiac Regeneration
Rationale: Although mammalian cardiac regeneration can occur in the neonatal period, the factors involved in this process remain to be established. Because tissue and limb regeneration require concurrent reinnervation by the peripheral nervous system, we hypothesized that cardiac regeneration also requires reinnervation. Objective: To test the hypothesis that reinnervation is required for innate neonatal cardiac regeneration.
Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations
Rationale: S-nitrosylation (SNO), an oxidative post-translational modification of cysteine residues, responds to changes in the cardiac redox-environment. Classic biotin-switch assay and its derivatives are the most common methods used for detecting SNO. In this approach, the labile SNO group is selectively replaced with a single stable tag. To date, a variety of thiol-reactive tags have been introduced.
S‐Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction
Background Mammalian heart regenerative activity is lost before adulthood but increases after cardiac injury. Cardiac repair mechanisms, which involve both endogenous cardiac stem cells (CSCs) and cardiomyocyte cell‐cycle reentry, are inadequate to achieve full recovery after myocardial infarction (MI). Mice deficient in S‐nitrosoglutathione reductase (GSNOR−⁄−), an enzyme regulating S‐nitrosothiol turnover, have preserved cardiac function after MI.
Growth Hormone-Releasing Hormone Agonists Reduce Myocardial Infarct Scar in Swine With Subacute Ischemic Cardiomyopathy
Background Growth hormone–releasing hormone agonists (GHRH‐As) stimulate cardiac repair following myocardial infarction (MI) in rats through the activation of the GHRH signaling pathway within the heart. We tested the hypothesis that the administration of GHRH‐As prevents ventricular remodeling in a swine subacute MI model. Methods and Results Twelve female Yorkshire swine (25 to 30 kg) underwent transient occlusion of the left anterior descending coronary artery (MI).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Wayne
Contact Wayne, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack